Table 1.
Overall N = 983 |
MDT/SB-A N = 610 |
MDT/SB-B N = 373 |
p-Value | |
---|---|---|---|---|
Female | 452 (46.0%) | 283 (46.4%) | 169 (45.3%) | 0.74 |
Age at diagnosis | 58.0 (1.0, 95.0) | 60.0 (8.0, 93.0) | 56.0 (1.0, 95.0) | 0.001 |
Bone tumors Chondrogenic Osteogenic Vascular Others/Unknown Soft-tissue tumors Adipocytic (Myo-)fibroblastic Fibrohistiocytic Muscle tumors Undifferentiated/un- classified Others |
44 (4.5%) 19 (1.9%) 18 (1.8%) 81 (8.2%) 201 (20.5%) 117 (11.9%) 33 (3.4%) 82 (8.3%) 87 (8.9%) 301 (30.6%) |
24 (3.9%) 6 (1.0%) 14 (2.3%) 60 (9.8%) 141 (23.1%) 59 (9.7%) 11 (1.8%) 51 (8.4%) 50 (8.2%) 194 (31.8%) |
20 (5.4%) 13 (3.5%) 4 (1.1%) 21 (5.6%) 60 (16.1%) 58 (15.6%) 22 (5.9%) 31 (8.3%) 37 (9.9%) 107 (28.6%) |
<0.001 |
Primary tumor site Appendicular Axial NA |
558 (56.8%) 367 (37.3%) 58 (5.9%) |
352 (57.7%) 220 (36.1%) 38 (6.1%) |
206 (55.2%) 147 (39.4%) 20 (5.4%) |
0.37 |
Metastasis at diagnosis | 44 (4.5%) | 26 (4.3%) | 18 (4.8%) | 0.75 |